Transcription Factor Activities Enhance Markers of Drug Sensitivity in CancerLuz García‐Alonso, Julio Sáez-Rodríguez, Mathew J. Garnett et al.|Cancer Research|2017Cited by 235
Synthetic Lethal Targeting of <i>ARID1A</i> -Mutant Ovarian Clear Cell Tumors with DasatinibRowan Miller, Alan Ashworth, Rachel Brough et al.|Molecular Cancer Therapeutics|2016Cited by 85
A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescenceGerard L. Brien, Adrian P. Bracken, Evan Healy et al.|Genes & Development|2015Cited by 40
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 AgonistsVera Grinkevitch, Simon S. McDade|Research Portal (Queen's University Belfast)|2022Cited by 3